baber/WOPTO huggingface dataset:
Patent IL-153449-A0 (IL)
Title: Reusable extracorporeal columns loaded with liganddibiotin conjugates
IPC: C07D495/04
Filed: 2001-06-18
Abstract: A method for the conditioning of an extracorporeal device is described, as well as method for extracorporeal extraction of toxic material from mammalian body fluids in connection with diagnosis or treatment of a mammalian condition or disease, in which methods reagents having the ability to extract toxic material from mammalian body fluids are involved, and an extracorporeal device comprising said reagent.
Patent IL-157755-A0 (IL)
Title: Method and device for determining the concentration of a substance in body liquid
IPC: A61B5/145
Filed: 2001-03-06
Abstract: For measuring the concentration of a substance in body fluid, such as the glucose level in blood or tissue, a strip electrode (18) and a ring electrode (19) are arranged at the specimen. The ring electrode (19) is in direct electrical contact with the specimen while the strip electrode (18) is electrically insulated therefrom. The strip electrode (18) is arranged parallel to an arm or a leg for obtaining a large interaction length. The electrodes (18, 19) form a capacitor in a resonant circuit. A modulated voltage in the MHz range close to or at the resonance frequency is applied to the electrodes and the response of the body fluid is measured. This design allows a measurement of high accuracy.
Patent IL-159295-A0 (IL)
Title: Authentication of a user across communication sessions
IPC: H04L29/06
Filed: 2002-06-11
Abstract: The invention relates to an apparatus and for facilitating the reauthentication of a user using a client computer to a server computer. In one embodiment, the method includes the steps of receiving, by the server, confidential information during a first communication session between the server and a client, encrypting the confidential information with a key to create encrypted confidential information, and storing the encrypted confidential information in the server's memory. The method also includes the steps of transmitting, by the server, the key to the client and deleting, by the server, the key from the server's memory. When the server receives the key from the client during a second communication session, the server uses the key to decrypt the encrypted confidential information.
Patent IL-164964-A0 (IL)
Title: Ultra-wideband communication through a wire network
IPC: H04L25/49
Filed: 2004-11-01
Abstract: A method to increase the available bandwidth across a wired network is provided. The method includes transmitting an ultra-wideband signal across the wired network. One embodiment of the present invention may transmit a multiplicity of ultra-wideband signals through a community access television network. The present invention may transmit an ultra-wideband signal across an optical network, a cable television network, a community antenna television network, a community access television network, a hybrid fiber-coax network, an Internet service provider network, and a PSTN network.
Patent IL-175641-A0 (IL)
Title: Hybrid cemened carbide composites
IPC: C22C1/05
Filed: 2006-05-15
Abstract: Embodiments of the present invention include hybrid composite materials comprising a cemented carbide dispersed phase and a cemented carbide continuous phase. The contiguity ratio of the dispersed phase of embodiments may be less than or equal to 0.48. The hybrid composite material may have a hardness of the dispersed phase that is greater than the hardness of the continuous phase. For example, in certain embodiments of the hybrid composite material, the hardness of the dispersed phase is greater than or equal to 88 HRA and less than or equal to 95 HRA and the hardness of the continuous phase is greater than or equal to 78 and less than or equal to 91 HRA. Additional embodiments may include hybrid composite materials comprising a first cemented carbide dispersed phase wherein the volume fraction of the dispersed phase is less than 50 volume percent and a second cemented carbide continuous phase, wherein the contiguity ratio of the dispersed phase is less than or equal to 1.5 times the volume fraction of the dispersed phase in the composite material. The present invention also includes a method of making a hybrid cemented carbide composite by blending partially and/or fully sintered granules of the dispersed cemented carbide grade with "green" and/or unsintered granules of the continuous cemented carbide grade to provide a blend. The blend may then be consolidated to form a compact. Finally, the compact may be sintered to form a hybrid cemented carbide.
Patent IL-179188-A0 (IL)
Title: Bacillus anthracis spore specific antobodies
Filed: 2006-11-12
Abstract: The invention relates to spore specific antibodies. Compositions and methods relating to the antibodies are provided along with the hybridomas that produce the antibodies. The antibodies are specific for the spores of Bacillus anthracis relative to the vegetative form of the cells. The antibodies are also specific for the spores relative to other Bacillus spores and cells. The antibodies may be used to detect the presence of Bacillus anthracis spores by use of methods provided herein. The invention also relates to articles of manufacture as well as kits comprising these antibodies which may be used in the detection methods of the invention.
Patent IL-187538-A0 (IL)
Title: Process for synthesis of dialkoxyorganoboranes
Filed: 2007-11-21
Abstract: The invention relates to a process for the synthesis of organo-oxazaborolidines of the structural formula   
wherein 
R 4  to R 8  is hydrogen, C 1 -C 20  alkyl, C 6 -C 14  aryl, C 7 -C 24  aralkyl, C 7 -C 24  alkaryl, substituted C 1 -C 20  alkyl 
or the two groups R 4  and R 5  together are a divalent group selected from the group consisting of -CH 2 CH 2 -, -CH(CH 3 )CH 2 -, -CH 2 CH 2 CH 2 -, -CH(CH 3 )CH(CH 3 )-, -CH(CH 2 CH 3 )CH 2 -, -C(CH 3 ) 2 C(CH 3 ) 2 -, -CH 2 C(CH 3 )2CH2- to form with the -NH-CR 6 - moiety a cyclic structure.
Patent IL-190289-A0 (IL)
Title: Method for obtaining human smooth muscular cells and uses thereof
IPC: C12N5/077
Filed: 2008-03-19
Abstract: The invention concerns a method for obtaining in vitro a population of cells comprising essentially human smooth muscular cells expressing calponin and SM-MHC from a sample of human muscular biopsy or from human muscular biopsies differentiated in vitro into skeletal muscle cells. The invention also concerns a composition comprising the isolated smooth muscular cells obtainable by said method as therapeutic principle designed for humans. The invention further concerns the use of the isolated smooth muscular cells for preparing a therapeutic composition designed to replace smooth muscular cells. In particular, the invention concerns the use of said isolated smooth muscular cells for treating ischemia, cancer or any disease requiring revascularization of damaged tissues. Finally, the invention concerns the use of said smooth muscular cells as vector for an active principle for preparing a therapeutic composition designed for humans requiring treatment with said active principle.
Patent IL-208801-A0 (IL)
Title: A method and system for identifying muzzle blast
Filed: 2010-10-18
Abstract: A method for identifying a muzzle blast within a signal generated by an array of acoustic sensors forming an antenna comprises defining a width for a time window corresponding to a time required for the muzzle blast to traverse the array of acoustic sensors and detecting a shockwave within the generated signal. After detecting the shockwave, total energy of the generated signal in a series of consecutive time windows as a function of time and as a function of the number of acoustic sensors that generated the signal is measured, each time window having the defined width. One of the consecutive time windows having a measured total energy greater than each of the remainder of the consecutive time windows is identified; and the identified time window is associated as corresponding to the muzzle blast.
Patent RO-128543-A0 (RO)
Title: Tracking mechanism for a string of photovoltaic modules
Inventor: TATU NICOLETA IRINA
IPC: F24J2/54
Filed: 2012-05-07
Abstract: The invention relates to a tracking mechanism used for driving simultaneously a string of photovoltaic modules. According to the invention, the mechanism comprises an electric motor () connected to a worm and wheel mechanism () which reduces the transmission ratio and ensures the irreversibility of motion, a worm gear being coupled to an axle () of the first photovoltaic module (), the transmission of the diurnal motion from East to West being achieved by means of a chain transmission () ensuring both the simultaneity of motion and the maintenance of the value of the rotation angle about some axes () for all the modules in the string, the latter being mounted on a metal support () which allows the string of modules to tilt at an optimal elevation angle, specific to a given geographical location, determined based on the latitude of the location.
Patent AP-2004003039-A0 (AP)
Title: Process for rendering nutritional and industrial properties in seeds easily assimilable.
Inventor: WEIDEMAN ANDRIES WILHELM JOHAN
IPC: A23B9/02
Filed: 2002-11-12
Abstract: The invention provides a process for rendering various nutritional and industrial properties in certain seeds of the plant families amaranthaceae, cruciferum, chenopodiaceae and brassica easily assimilable and/or suitable for industrial use, the process including the steps of continuously heating seeds to a predetermined temperature, stabilising seeds at the temperature and then allowing the seeds to cool to ambient conditions.
Patent IE-910096-A1 (IE)
Title: PYRIDAZINO [4,5-b] INDOLIZINES
IPC: C07D519/00
Filed: 1991-01-11
Abstract: The compound of the formula: in which R1 is hydrogen, alkoxy, cyano, halo, nitro, amino, or mono- or dialkylamino; R2 is hydrogen, alkyl, phenyl, benzyl, 2-thienyl, 3-thienyl or 2-,3- or 4-pyridinyl; R3 is hydrogen, alkyl or phenyl; R4 is N-methyl-pyrrolidin-2yl, 2-, 3- or 4-pyridinyl, 3-quinuclidinyl or where n is 1 to 5; m is 0 to 3; and R8 is hydrogen or alkyl of 1 to 6 carbon atoms; or R4 is wherein: (a) n is 2, R5 taken with R3 is ethylene and R6 is -CHO, alkyl, unsubstituted or substituted phenyl, pyrimidinyl, pyridinyl, or pyrazinyl, where the substituents are alkyl, alkoxyl, halo, cyano, nitro or trifluoromethyl; (b) n is 1 to 5, and R5 and R6 taken together are polymethylene which may be alkyl substituted or R5 nd R6 are morpholino, 3-azabicyclo[3.2.2]nonan-3-yl, pyrrol-1-yl, pyrrolidin-2-on-1-ytl, pyrrolidin-2-thion-1-yl, imidazol-1-yl, alkyl-piperidin-1-yl or a piperazin-1-yl moiety in the 4-position of which is hydrogen, -CHO, alkyl or unsubstituted or substituted phenyl, pyrimidinyl, pyridinyl, or pyrazinyl, alkoxy, halo, cyano, nitro or trifluoromethyl; or (c) n is 1 to 5, and R5 and R6 are, independently, hydrogen, alkyl, phenyl, 3-quinuclidinyl, 2-adamantyl, bicyclo[3.2.1]octan-1-yl, bicyclo[3.3.1]nonan-9-yl or 2-,3- or 4- pyridinyl; or a pharmaceutically acceptable salt thereof are M1 receptor agonists useful in treatment of dementias involving the cholinergic system.
Patent IE-910442-A1 (IE)
Title: Attachment for use with a shear grab
IPC: A01K5/00
Filed: 1991-02-11
Abstract: There is disclosed an attachment (28) for use with a shear grab (22-27), the attachment (28) being disposable in either an inoperative (Fig. 3) or an operative (Fig. 4) position, in which latter it is capable of shredding/comminuting a block of silage cut by the shear grab (22-27) and of delivering the silage to an animal feeding location in its shredded/comminuting form.
Patent LU-78840-A1 (LU)
Inventor: TREYSSAC G
IPC: B03D1/02
Filed: 1978-01-10
Abstract: A flotation apparatus comprising a treatment chamber provided, at one of its ends, with an inlet for the liquid to be treated circulating without turbulence and, at the other end, an outlet for the treated liquid, an inlet pipe for the treatment water under high compression charged with gas being disposed at the lower part of said treatment chamber.
Patent LU-88122-A1 (LU)
IPC: A61K/
Filed: 1992-05-27
Abstract: Following are described. (A) purified prepn. of an anti-CDw52 antibody which exhibits on size exclusion chromatography a single peak under non-reducing conditions and 2 major peaks under reducing conditions; esp. the prepn. exhibits on conventional SDS polyacrylamide gel electrophoresis, one main band using a non-reduced sample and two main bands using a reduced sample; (B) purified prepn. of an anti-CDw52 antibody having a specific activity greater than 0.8 KU/mg; (C) purified prepn. of an anti-CDw52 antibody, free from host cell contaminants and/or aggregates; (D) purifying an anti-CDw52 antibody comprising (a) applying an aqs. soln. of the antibody to a Protein A column so as to absorb the antibody and eluting the antibody with an acid soln., (b) applying the acidic eluate to an ion-exchange column of charged particles to absorb the antibody and then eluting the antibody with an aqs. soln. of counter-charged ions and (c) applying the aqs. eluate to a size exclusion column of porous particles to retain non-antibody mols. in the porous particles and to obtain the desired antibody in selected fractions produced from the column. Pref. the Protein A column is Protein A Sepharose and the antibody is eluted with citric acid.
Patent LU-88212-A1 (LU)
Inventor: KERGER LEON
IPC: F17C5/00
Filed: 1993-01-15
Abstract: The device is designed for a valve with or without a residual-pressure valve element and is intended to fill the bottle and to create a vacuum therein, optionally through the residual-pressure valve element. It includes a rotary axial shaft (56) with an eccentric tip (58) intended to lift the residual-pressure valve element by rotation of the shaft (56). The rotation of the shaft (56) is brought about by a pneumatic piston (72) which is automatically actuated by connecting the device to a vacuum pump.
Patent MA-25331-A1 (MA)
Inventor: ALBERS MARKUS
IPC: C07D417/12
Filed: 2001-06-13
Abstract: The present invention relates to biphenyl and biphenyl-analogous compounds, their preparation and use as pharmaceutical compositions, as integrin antagonists and in particular for the production of pharmaceutical compositions for the treatment and prophylaxis of cancer, arteriosclerosis, restenosis, osteolytic disorders such as osteoporosis and ophthalmic diseases. The compounds according to the invention have formula (1) wherein R<1>, R<2>, U, V, A, B, W, R<3>, C and R<4> have the meaning as defined in the claims.
Patent MA-25495-A1 (MA)
Inventor: GARNETT DAVID JOHN
IPC: A61K31/216
Filed: 2002-03-22
Abstract: Use of the compound of general formula (I) wherein Y is an alkoxy group having 1 to 4 carbon atoms, a hydroxyl group, an amine group, a halide group or a nitro group; X is a hydroxyl group, an amine group, a halide group, a nitro group, an alkoxy group or an ester group and n is 0 or 1, in the preparation of a medicament for the treatment of parasitic infestations of organisms.
Patent MA-27231-A1 (MA)
Title: Systeme de carte de debit rechargeable et procede associe
Inventor: WILLARD RICK L
IPC: G06Q20/00
Filed: 2004-08-23
Abstract: La présente invention permet à un client de charger de l'argent sur une carte en temps réel à l'aide d'une technologie existante via le réseau de guichets automatiques existant au moyen d'une déclaration à solde débiteur en utilisant un numéro d'identification personnel (ou d'une correction ou redressement de débit utilisant un code de transaction spécifique). L'argent peut ensuite être chargé en temps réel (par exemple en moins de 120 secondes) sur une carte anonyme à valeur stockée, de débit, de guichet automatique, polyvalente ou de transaction privée utilisant un PIN. L'invention prévoit également le chargement de l'argent sur une ou plusieurs cartes avec ou sans les mêmes numéros de compte.
Patent MA-37347-A1 (MA)
Title: Agrégation de ressources dans des canaux de commande améliorés
Inventor: LARSSON DANIEL
IPC: H04L5/00
Filed: 2013-03-19
Abstract: L'ensemble de niveaux d'agrégation de ressources disponible pour former un message de canal de commande amélioré peut varier d'une sous-trame à une autre, en fonction du niveau de perforation dans les sous-trames transmises. Un procédé décrit dans la présente invention consiste à déterminer (2710) des membres d'un ensemble de niveaux d'agrégation utilisable pour agréger les sous-ensembles non en chevauchement d'éléments de ressources pour transmettre des données de commande sur la liaison descendante. Ladite détermination est basée sur un niveau de perforation devant être utilisé pour la transmission des données de commande sur la liaison descendante. Des données de commande sur la liaison descendante pour la sous-trame donnée sont mises en correspondance (2720) par rapport à un ou plusieurs sous-ensembles non en chevauchement d'éléments de ressources dans le ou les blocs de ressources temps-fréquence, en fonction d'un niveau d'agrégation sélectionné à partir de l'ensemble déterminé, et elles sont ensuite transmises (2730), dans le ou les sous-ensembles non en chevauchement d'éléments de ressources. Ce procédé peut être répété pour chacune de plusieurs sous-trames, la perforation pouvant varier d'une sous-trame à une autre.
Patent MA-37428-A1 (MA)
Title: Plants de tomate à rendement élevé
Inventor: SHALEV GIL
IPC: A01H1/04
Filed: 2013-04-18
Abstract: La présente invention concerne un plant de tomate présentant un phénotype à inflorescence ramifiée. Ledit plant fournit un rendement significativement élevé d'un point de vue statistique en fruits mûrs ayant des propriétés de poids moyen par fruit individuel ou de degrés brix moyens par fruits individuel ou une combinaison de ces propriétés, qui sont similaires à celles des fruits produits par une lignée de tomate qui est employée comme lignée parent normalement ramifiée dudit plant de tomate. L'invention a également pour objet des procédés pour produire lesdits plants de tomate et leurs utilisations.
Patent MA-39449-A1 (MA)
Title: Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci
Inventor: PARDAL FILIPE AUGUSTO EUGÉNIO
IPC: C07D487/06
Filed: 2014-05-09
Abstract: La présente invention concerne un nouveau procédé d'obtention d'énantiomères de pirlindole optiquement actifs, sous forme d'une base libre ou sous forme de sels pharmaceutiquement acceptables. Les produits obtenus selon la présente invention sont énantiomériquement purs et sont utiles en médecine.
Patent MA-44550-A1 (MA)
Title: Anticorps anti-acide téichoique de la paroi cellulaire et conjugués associés
Inventor: VANDLEN RICHARD
IPC: C07K16/12
Filed: 2014-05-30
Abstract: La présente invention concerne des anticorps anti-acide téichoïque de la paroi cellulaire et leurs conjugués antibiotiques, ainsi que leurs méthodes d'utilisation.
Patent UY-23631-A1 (UY)
Title: Un procedimiento para la preparacion de harina de trigo integral de duracion estable
Inventor: CHAWAN DHYANESHWAR BHUJANGARAO
IPC: A23L7/109
Filed: 1993-08-12
Abstract: Se describe un procedimiento para la preparación de harina de trigo integral de duración estable que comprende moler el trigo integral hasta formar una harina de trigo integral gruesa con tamaño de partícula esencialmente por sobre aproximadamente el número de tamiz Estadounidense Nº60, caracterizado porque el germen de trigo no es separado de los otros componentes de trigo, y el germen de trigo es preservado inacto, por lo cual la harina de trigo integral de molienda gruesa producida de esta manera exhibe una duración de conservación sin refrigerar de más de un año, sin agregado de conservantes, según se determinó por ausencia de amargor. Dicha harina posee un sabor similar a nuez, dulce, en comparación con la harina de trigo integral molida finamente en la cual el germen de trigo es separado. El trigo se selecciona de por ejemplo Fanfarrón, Rojo Duro de Primavera, entre otros, equivalentes y mezclas de los mismos. Además se describe un procedimiento para producir pastas de trigo integral mejorado.
Patent UY-23820-A1 (UY)
Title: Cintas de sujecion y metodo para su construccion.
Inventor: DILNIK LYN
IPC: A61F13/15
Filed: 1994-08-16
Abstract: Se describe una cinta de sujeción mejorada para usarse sobre una prenda absorbente desechable. La cinta de sujeción comprende un primer sustrato y un material de interconexión sujeto a dicho primer sustrato. El material de interconexión se extiende al ancho completo de la cinta de sujeción, y el material de entrecierre está espaciado longitudinalmente de ambos bordes transversales de la cinta de sujeción. Un procedimiento continuo para la fabricación de cintas de sujeción para uso en prendas absorbentes desechables , el cual comprende: proporcionar dos largos continuos de un material de interconexión espaciados de forma lateral; unir dichos dos largos continuos de material de interconección a un primer sustrato con un amncho y desplazándose en dicha primera dirección para formar un armado de cintas; cortar en tiras dicho armado de cintas en la primera dirección y cortar dicho compuesto de cintas a lo largo de una segunda dirección para formar cintas de sujeción, siendo la segunda dirección sustancialmente perpendicular a la primera dirección, en el cual dicho material de interconexión se encuentra unido al primer sustrato a lo largo de un tramo inferior a la totalidad del ancho del primer sustrato para definir bordes no adheridos y en el cual los bordes no adheridios se hallan ubicados a lo largo de cada borde longitudinal del material de interconexión.
Patent UY-24867-A1 (UY)
Title: Compuestos insecticidas de oxadiacina
Inventor: MCDONALD PAUL THOMAS
IPC: C07D413/04
Filed: 1998-01-30
Abstract: El presente invento está relacionado con un compuesto que tiene la fórmula (I), en la que R es un grupo heterocíclico C4-C5 que contiene un átomo de nitrógeno, azufre u oxígeno, en la que el grupo heterocíclico puede ser sustituido o no sustituido con 1 a 3 átomos de halógeno, o con un grupo haloalquil C1-C4; R' es hidrógeno, halógeno, haloalquil C1-C4 o haloalcoxi C1-C4. Estos compuestos, o las sales fisiológicamente aceptables de éstos, son útiles como insecticidas. Las composiciones insecticidas de este invento contienen: a- una cantidad eficaz de uno o más compuestos de la fórmula I, y b- un transportador adecuado. Un método para controlar insectos que comprende la aplicación sobre un lugar a proteger que no es un cuerpo humano o animal, de una cantidad eficaz del compuesto de fórmula l. Un ejemplo de un compuesto de fórmula l sería: 5,6-dihidro-N-[4-(trifluorometoxi)-fenil-2-(5-bromo-2-tienil)4H-1,3,4-oxadiacina-4-carboxamida
Patent UY-26864-A1 (UY)
Title: Composiciones farmaceúticas de inhibidores de la proteína de transferencia de colesteril éster
Inventor: SHANKER RAVI MYSORE
IPC: A61K31/56
Filed: 2001-08-01
Abstract: Una composición farmacéutica comprende una dispersión amorfa de sólidos de un inhibidor de la proteína de transferencia de colesteril éster y un polímero que aumenta la concentración.
Patent UY-28384-A1 (UY)
Title: Nuevo compuesto de imidazopiridina ii con efecto terapeutico
Inventor: NORDBERG PETER
IPC: C07D/
Filed: 2004-06-24
Abstract: La presente invención se refiere a derivados de imidazopiridina de Fórmula I que inhiben de forma exógena o endógena la secreción estimulada de ácido gástrico y de esta forma puede utilizarse en el tratamietno de enfermedades vinculadas al ácido gástrico o enfermedades inflamatorias gastrointestinales.
Patent UY-29349-A1 (UY)
Title: Inhibicion de los objetivos de la hipertensión ocular mediada por arni
Inventor: CLARK ABBOT F
IPC: C07H21/02
Filed: 2006-01-26
Abstract: Se presenta la interferencia del ARN inhibir la expresión del ARNm del objetivo de la hipertensión ocular a los efectos de reducir la presión intraocular elevada de los pacientes que sufren de glaucoma de ángulo abierto o hipertensión ocular. Los objetivos de la hipertensión ocular incluyen las anhidrasas carbónicasII, IV y XII, los receptores adrenérgicos B(Beta)1 y B(Beta)2, la acetilcolinesterasa, Na+/K+-ATPasa y el cotransportar Na-K-2C1. La hipertensión ocular se trata administrando los ARNi del presente invento.